Skip to main content
Cureus logoLink to Cureus
. 2021 Feb 11;13(2):e13288. doi: 10.7759/cureus.13288

Actinotignum schaalii Caught for the Second Time in Fournier's Gangrene!

Syeda Sahra 1,, Abdullah Jahangir 1, Harika Kandlakunta 1, Allison Glaser 2
Editors: Alexander Muacevic, John R Adler
PMCID: PMC7955795  PMID: 33728221

Abstract

Actinotignum schaalii, a Gram-positive rod residing in the urinary tract, is responsible for urinary tract infections and their complications including but not limited to bacteremia and sepsis. A. schaalii is increasingly being detected in body fluid specimens owing to advancements in PCR techniques. This report describes an interesting case of an adult diabetic patient managed for Fournier's gangrene. A. schaalii was detected in the PCR of his wound cultures. To the best of our knowledge, this is the second case of A. schaalii as the causative agent for Fournier's gangrene.

Keywords: actinotignum schaali, actinobaculum schaali, fournier’s gangrene

Introduction

Actinotignum schaalii, formerly Actinobaculum schaalii, causes urinary tract infections in elderly patients [1-3], and rarely in juvenile patients with pelvi-ureteral junction (PUJ) abnormality [4]. It is reported to cause bacteremia, cellulitis, vertebral osteomyelitis [5], necrotizing fasciitis, and infectious endocarditis [6].

Fournier’s gangrene is necrotizing fasciitis affecting the genital and perineal region predominantly in males [7,8], with a history of diabetes mellitus, alcohol dependency, immobilization, active smoking, and immunosuppression [9,10]. So far, only one case has been reported where it grew in tissue samples taken from Fournier’s gangrene [11]. The pathogen responded appropriately to antibiotics and the patient subsequently recovered from the infection. We present this case to the medical community to be aware of the increasing prevalence and detection of A. schaalii in culture studies from body fluids. Culturing of A. schaalii has been historically difficult. With the advent of modified techniques in detecting molecular targets in PCRs with high accuracy, the incidence of A. schaalii is expected to be higher in the future.

Case presentation

A 45-year-old gentleman, an active smoker, with a prior medical history of morbid obesity, diabetes (controlled, latest hemoglobin a1c: 5.6 mmol/mol), sleep apnoea, hypothyroidism, narcolepsy, and chronic back pain with a history of L3-L4 laminectomy presented to the emergency room with testicular pain for past one day. His pain started the night before presentation when he noticed a painful boil on his right upper thigh, which progressively got worse over the day. The boil was associated with subjective fevers and chills.

The vital signs and blood work on presentation were suggestive of sepsis (temperature: 101.7 F, HR 131 beats per minute, respiratory rate of 22 breaths per minute, WBC 22.6 with predominant neutrophilia, lactate 1.9 mmol/L). On physical examination, the right inguinal region was erythematous, tender to palpation, and indurated with deep crepitus. The scrotum overall was enlarged, with the right hemi-scrotum being erythematous without induration or crepitus.

CT of abdomen and pelvis was performed, which showed inflammatory changes and gas (consistent with infection with the gas-forming organism, e.g., Fournier's gangrene) noted in the right inguinal region with extension into the right side of the scrotum and scrotal edema. No extension of inflammation into the pelvis itself or perianal/perirectal region was seen (Figure 1).

Figure 1. Computed tomography of abdomen and pelvis showing inflammatory changes and gas noted in the right inguinal region with extension into the right side of the scrotum and scrotal edema.

Figure 1

The patient was started on intravenous fluids and antibiotics and underwent incision and debridement of right scrotum soft tissue on hospital day 2. Operative findings were significant for right groin necrotic tissue, deep to subcutaneous tissue, and fascia. The necrotic tissue was debrided, tissue samples were sent for Gram staining and cultures. Blood cultures were negative. Initial wound culture and sensitivity showed moderate anaerobic Gram-negative Rods. Vancomycin was stopped and IV cefepime and IV clindamycin were continued.

Repeat debridement of the right scrotum was done three days later. Operative findings showed granulating wounds with purulent drainage and fat necrosis. The cultures from the first debridement showed A. schaalii group detected on Bruker MALDI Biotyper (MALDI-TOF MS system, Bruker Daltonics, Billerica, MA). Antibiotics were switched to Rocephin and clindamycin.

He was discharged home on oral Augmentin for eight more days. The patient was re-evaluated four months later. The site of the previous infection in the right hemiscrotum was healing appropriately.

Discussion

Actinotignum schaalii, Actinotignum urinale, and Actinotignum sanguinis are included in the genus Actinotignum [12]. A. schaalii (reclassified in 1997 [13]) is one of the slow-growing, Gram-positive, catalase-negative, facultative rods that inhabit the urinary tract [12]. Multiple pathogens are responsible for necrotizing fasciitis of the groin called Fournier’s gangrene. The mortality rate is exceptionally high in high-risk individuals (with diabetes mellitus, underlying immunosuppression, and tobacco abuse).

Our patient was predisposed to Fournier's gangrene as he was obese, an active smoker, and diabetic. Like mentioned earlier, A. schaalii is present in urinary tracts. The immunosuppression from smoking and diabetes can lead to the exponential growth of A. schaalii, leading to necrotizing fasciitis in the groin area. Fournier's gangrene is traditionally only reported in males. The pathogens most commonly encountered in Fournier's gangrene include group A Streptococcus, Staphylococcus aureus, Pseudomonas, and E. Coli. To the best of our knowledge, this is the second case of the presence of A. schaalii being documented in Fournier’s gangrene [11]. There is a possibility of genital and perianal gangrene and necrotizing fasciitis due to A. schaalii in the female population as well as risk factors like diabetes, smoking, alcoholism, and obesity. The invasive nature of A. schaalii is evident from its infections in vertebral bodies and septicaemia. The course of treatment can be prolonged with possible recurrence in the presence of co-morbidities like diabetes and active tobacco usage.

Conclusions

The opportunistic growth of A. schaalii from the urinary tract has the potential to cause necrotizing fasciitis. The second case of Fournier's gangrene secondary to A. schaalii is being reported. Physicians need to be mindful of its presence in the human urinary tract and increased detection owing to PCR assays.

The content published in Cureus is the result of clinical experience and/or research by independent individuals or organizations. Cureus is not responsible for the scientific accuracy or reliability of data or conclusions published herein. All content published within Cureus is intended only for educational, research and reference purposes. Additionally, articles published within Cureus should not be deemed a suitable substitute for the advice of a qualified health care professional. Do not disregard or avoid professional medical advice due to content published within Cureus.

The authors have declared that no competing interests exist.

Human Ethics

Consent was obtained or waived by all participants in this study

References

  • 1.Actinobaculum schaalii, a common uropathogen in elderly patients, Denmark. Bank S, Jensen A, Hansen TM, Søby KM, Prag J. Emerg Infect Dis. 2010;16:76–80. doi: 10.3201/eid1601.090761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Urosepsis with Actinobaculum schaalii and Aerococcus urinae. Sturm PD, Van Eijk J, Veltman S, Meuleman E, Schülin T. J Clin Microbiol. 2006;2:652–654. doi: 10.1128/JCM.44.2.652-654.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Actinobaculum schaalii: a common cause of urinary tract infection in the elderly population. Bacteriological and clinical characteristics. Nielsen HL, Søby KM, Christensen JJ, Prag J. Scand J Infect Dis. 2010;42:43–47. doi: 10.3109/00365540903289662. [DOI] [PubMed] [Google Scholar]
  • 4.Pyelonephritis caused by Actinobaculum schaalii in a child with pyeloureteral junction obstruction. Pajkrt D, Simoons-Smit AM, Savelkoul PH, van den Hoek. Eur J Clin Microbiol Infect Dis. 2003;22:438–440. doi: 10.1007/s10096-003-0933-3. [DOI] [PubMed] [Google Scholar]
  • 5.Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen. Haller P, Bruderer T, Schaeren S, et al. Eur J Clin Microbiol Infect Dis. 2007;26:667–670. doi: 10.1007/s10096-007-0345-x. [DOI] [PubMed] [Google Scholar]
  • 6.Endocarditis caused by Actinobaculum schaalii, Austria. Hoenigl M, Leitner E, Valentin T, Zarfel G, Salzer HJ, Krause R, Grisold AJ. Emerg Infect Dis. 2010;16:1171–1173. doi: 10.3201/eid1607.100349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Fournier's gangrene: a review of 1726 cases. Eke N. Br J Surg. 2000;87:718–728. doi: 10.1046/j.1365-2168.2000.01497.x. [DOI] [PubMed] [Google Scholar]
  • 8.Fournier's Gangrene: population based epidemiology and outcomes. Sorensen MD, Krieger JN, Rivara FP, Broghammer JA, Klein MB, Mack CD, Wessells H. J Urol. 2009;181:2120–2126. doi: 10.1016/j.juro.2009.01.034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.New insights into the epidemiology and etiology of Fournier's gangrene: a review of 33 patients. Czymek R, Hildebrand P, Kleemann M, et al. Infection. 2009;37:306–312. doi: 10.1007/s15010-008-8169-x. [DOI] [PubMed] [Google Scholar]
  • 10.Actinobaculum schaalii as a uropathogen in immunocompromised hosts. Ghadian A. https://pubmed.ncbi.nlm.nih.gov/22976256/ Iran J Kidney Dis. 2012;6:332–333. [PubMed] [Google Scholar]
  • 11.Actinobaculum schaalii causing Fournier's gangrene. Vanden Bempt I, Van Trappen S, Cleenwerck I, De Vos P, Camps K, Celens A, Van De Vyvere M. J Clin Microbiol. 2011;49:2369–2371. doi: 10.1128/JCM.00272-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Actinotignum schaalii (formerly Actinobaculum schaalii): a newly recognized pathogen-review of the literature. Lotte R, Lotte L, Ruimy R. Clin Microbiol Infect. 2016;22:28–36. doi: 10.1016/j.cmi.2015.10.038. [DOI] [PubMed] [Google Scholar]
  • 13.Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. Lawson PA, Falsen E, Akervall E, Vandamme P, Collins MD. Int J Syst Bacteriol. 1997;47:899–903. doi: 10.1099/00207713-47-3-899. [DOI] [PubMed] [Google Scholar]

Articles from Cureus are provided here courtesy of Cureus Inc.

RESOURCES